Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS

Suresh Garudadri, Prescott G. Woodruff, Mei Lan K. Han, Jeffrey L. Curtis, R. Graham Barr, Eugene R. Bleecker, Russell P. Bowler, Alejandro Comellas, Christopher B. Cooper, Gerard Criner, Mark T. Dransfield, Nadia N. Hansel, Robert Paine, Jerry A. Krishnan, Stephen P. Peters, Annette T. Hastie, Fernando J. Martinez, Wanda K. O'Neal, David J. Couper, Neil E. AlexisStephanie A. Christenson

Research output: Contribution to journalArticlepeer-review

17 Scopus citations


Background: Chronic respiratory symptoms and exacerbation-like events are common among ever-smokers without airflow limitation on spirometry. The pathobiology of respiratory disease in this subgroup remains poorly defined, but may be due to underlying inflammation that overlaps with COPD or asthma. We hypothesized that symptoms, exacerbations, and functional measures of disease severity among smokers with preserved spirometry would be associated with markers of systemic inflammation, similar to what is reported in bone fide COPD, rather than elevated type 2 inflammation, which is often present in asthma. Methods: We measured inflammatory markers associated with COPD (C-reactive protein [CRP], fibrinogen, soluble tumor necrosis factor receptors [sTNFRSF1A and sTNFRSF1B], and blood/sputum neutrophils) and type 2 inflammation (IgE and blood/sputum eosinophils) in smokers with preserved spirometry (postbronchodilator FEV1/FVC ≥ 0.70) from the Subpopulations and Intermediate Outcome Measures In COPD Study (SPIROMICS). We evaluated the relationship of these markers with respiratory symptom burden (dichotomized by a COPD assessment test score cutoff of 10, diagnosis of chronic bronchitis), exacerbations, 6-minute walk distance, and lung function on the basis of FEV1. Results: CRP was associated with increased symptom burden (on the basis of COPD assessment test score and diagnosis of chronic bronchitis) and a greater number of exacerbations in the year before study enrollment. sTNFRSF1A was associated with symptom burden on the basis of COPD assessment test score. CRP and sTNFRSF1A levels negatively correlated with 6-minute walk distance. IgE and eosinophils were not associated with these outcomes. Conclusions: Markers of inflammation including CRP and sTNFRSF1A are enriched among symptomatic smokers with preserved spirometry, suggesting an overlap with the underlying pathophysiology of COPD.

Original languageEnglish (US)
Pages (from-to)908-917
Number of pages10
Issue number5
StatePublished - May 2019


  • C-reactive protein
  • COPD
  • bronchitis
  • smoking

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS'. Together they form a unique fingerprint.

Cite this